{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:24:53Z","timestamp":1773332693497,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T00:00:00Z","timestamp":1476748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010749","name":"Hungarian Medical Research Council","doi-asserted-by":"crossref","award":["ETT 534\/2006"],"award-info":[{"award-number":["ETT 534\/2006"]}],"id":[{"id":"10.13039\/100010749","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003549","name":"OTKA","doi-asserted-by":"crossref","award":["K104903"],"award-info":[{"award-number":["K104903"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Janos Bolyai Research Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s12253-016-0132-z","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T04:44:13Z","timestamp":1476765853000},"page":"165-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia"],"prefix":"10.1007","volume":"23","author":[{"given":"Zolt\u00e1n","family":"M\u00e1trai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajnalka","family":"Andrikovics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anik\u00f3","family":"Szilv\u00e1si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Bors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Kozma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"\u00c1d\u00e1m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Halm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9va","family":"Kar\u00e1szi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Tordai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Masszi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"issue":"6","key":"132_CR1","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94(6):1848\u20131854","journal-title":"Blood"},{"key":"132_CR2","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F et al (1999) IgV Gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840\u20131847","journal-title":"Blood"},{"key":"132_CR3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/asheducation.V2012.1.76.3806845","volume":"2012","author":"N Chiorazzi","year":"2012","unstructured":"Chiorazzi N (2012) Implications of new prognostic markers in chronic lymphocytic leukemia. Hematology 2012:76\u201387","journal-title":"Hematology"},{"key":"132_CR4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","volume":"100","author":"A Kr\u00f6ber","year":"2002","unstructured":"Kr\u00f6ber A, Seiler T, Benner A, Bullinger L, Br\u00fcckle E, Lichter P, D\u00f6hner H, Stilgenbauer S (2002) VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100:1410\u20131416","journal-title":"Blood"},{"issue":"11","key":"132_CR5","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","volume":"194","author":"A Rosenwald","year":"2001","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G et al (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194(11):1639\u20131647","journal-title":"J Exp Med"},{"issue":"11","key":"132_CR6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","volume":"194","author":"U Klein","year":"2001","unstructured":"Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, Neri A, Califano A, Dalla-Favera R (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 194(11):1625\u20131638","journal-title":"J Exp Med"},{"issue":"2","key":"132_CR7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2004-08-3344","volume":"106","author":"P Oppezzo","year":"2005","unstructured":"Oppezzo P, Vasconcelos Y, Settegrana C et al (2005) The LPL\/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood 106(2):650\u2013657","journal-title":"Blood"},{"issue":"7","key":"132_CR8","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.leu.2403748","volume":"19","author":"D Heintel","year":"2005","unstructured":"Heintel D, Kienle D, Shehata M et al (2005) High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 19(7):1216\u20131223","journal-title":"Leukemia"},{"issue":"6","key":"132_CR9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/10428190500464161","volume":"47","author":"H N\u00fcckel","year":"2006","unstructured":"N\u00fcckel H, H\u00fcttmann A, Klein-Hitpass L, Schroers R, F\u00fchrer A, Sellmann L, D\u00fchrsen U, D\u00fcrig J (2006) Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 47(6):1053\u20131061","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"132_CR10","first-page":"56","volume":"91","author":"MB van\u2019t Veer","year":"2006","unstructured":"van\u2019t Veer MB, Brooijmans AM, Langerak AW et al (2006) The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 91(1):56\u201363","journal-title":"Haematologica"},{"issue":"2","key":"132_CR11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1373\/clinchem.2006.076331","volume":"53","author":"F Van Bockstaele","year":"2007","unstructured":"Van Bockstaele F, Pede V, Janssens A, Callewaert F, Offner F, Verhasselt B, Philipp\u00e9 J (2007) Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. Clin Chem 53(2):204\u2013212","journal-title":"Clin Chem"},{"issue":"5","key":"132_CR12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/10428190701245112","volume":"48","author":"EA Nikitin","year":"2007","unstructured":"Nikitin EA, Malakho SG, Biderman BV et al (2007) Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 48(5):912\u2013922","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"132_CR13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1751-553X.2008.01078.x","volume":"31","author":"W Xu","year":"2009","unstructured":"Xu W, Li JY, Shen QD, Wu YJ, Yu H, Fan L (2009) Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors. Int J Lab Hematol 31(5):552\u2013559","journal-title":"Int J Lab Hematol"},{"issue":"8","key":"132_CR14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3324\/haematol.2010.039396","volume":"96","author":"MA Kaderi","year":"2011","unstructured":"Kaderi MA, Kanduri M, Buhl AM et al (2011) LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia. Haematologica 96(8):1153\u20131160","journal-title":"Haematologica"},{"key":"132_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12700","author":"L Kristensen","year":"2015","unstructured":"Kristensen L, Kristensen T, Abildgaard N et al (2015) LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations. Eur J Haematol . doi: 10.1111\/ejh.12700 17 Dec","journal-title":"Eur J Haematol"},{"issue":"12","key":"132_CR16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00109-002-0384-9","volume":"80","author":"JR Mead","year":"2002","unstructured":"Mead JR, Irvine SA, Ramji DP (2002) Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 80(12):753\u2013769","journal-title":"J Mol Med"},{"issue":"3","key":"132_CR17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1158\/1535-7163.MCT-10-0802","volume":"10","author":"NB Kuemmerle","year":"2011","unstructured":"Kuemmerle NB, Rysman E, Lombardo PS et al (2011) Lipoprotein lipase links dietary fat to solid tumor cell proliferation. Mol Cancer Ther 10(3):427\u2013436","journal-title":"Mol Cancer Ther"},{"key":"132_CR18","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1182\/blood.V124.21.4490.4490","volume":"124","author":"R Dashnamoorthy","year":"2014","unstructured":"Dashnamoorthy R, Abermil N, Behesti A et al (2014) The lipid addiction of diffuse large B-cell lymphoma and potential treatment strategies with novel fatty acid synthase (FASN) small molecule inhibitors. Blood 124:4490","journal-title":"Blood"},{"issue":"4","key":"132_CR19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.plipres.2013.08.005","volume":"52","author":"N Zaidi","year":"2013","unstructured":"Zaidi N, Lupien L, Kuemmerle NB, Kinlaw WB, Swinnen JV, Smans K (2013) Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. Prog Lipid Res 52(4):585\u2013589","journal-title":"Prog Lipid Res"},{"key":"132_CR20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1158\/1541-7786.MCR-14-0412","volume":"13","author":"U Rozovski","year":"2015","unstructured":"Rozovski U, Grgurevic S, Bueso-Ramos C et al (2015) Aberrant LPL expression, driven by STAT3, mediates free fatty acid metabolism in CLL cells. Mol Cancer Res 13:944\u2013953","journal-title":"Mol Cancer Res"},{"key":"132_CR21","first-page":"1","volume":"8","author":"U Rozovski","year":"2015","unstructured":"Rozovski U, Hazan-Halevy I, Barzilai M, Keating MJ, Estrov Z (2015) Metabolism pathways in chronic lymphocytic leukemia. Leuk Lymphoma 8:1\u20138","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"132_CR22","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ Dongen van","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Br\u00fcggemann M, Evans PA, Hummel M, Lavender FL et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 17(12):2257\u20132317","journal-title":"Leukemia"},{"issue":"9","key":"132_CR23","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1080\/10428190410001710812","volume":"45","author":"C Matthews","year":"2004","unstructured":"Matthews C, Catherwood M, Morris TC, Alexander HD (2004) Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols. Leuk Lymphoma 45(9):1899\u20131904","journal-title":"Leuk Lymphoma"},{"key":"132_CR24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0001-2998(78)80014-2","volume":"8","author":"CE Metz","year":"1978","unstructured":"Metz CE (1978) Basic principles of ROC analysis. Semin Nucl Med 8:283\u2013298","journal-title":"Semin Nucl Med"},{"issue":"11","key":"132_CR25","first-page":"671a","volume":"102","author":"Z Matrai","year":"2003","unstructured":"Matrai Z, Sherrington PD, Pettitt AR, Zuzel M, Cawley JC (2003) CD38 expression in CLL is a marker of cell cycling activity. Blood 102(11):671a","journal-title":"Blood"},{"key":"132_CR26","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2007-04-083832","volume":"110","author":"RN Damle","year":"2007","unstructured":"Damle RN, Temburni S, Calissano C, Yancopoulos S, Banapour T, Sison C, Allen SL, Rai KR (2007) Chiorazzi N. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood 110:3352\u20133359","journal-title":"Blood"},{"key":"132_CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1074\/jbc.M107474200","volume":"277","author":"M Zubiaur","year":"2002","unstructured":"Zubiaur M, Fern\u00e1ndez O, Ferrero E, Salmer\u00f3n J, Malissen B, Malavasi F, Sancho J (2002) CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt\/protein kinase B and Erk activation in the absence of the CD3- immune receptor tyrosine-based activation motifs. J Biol Chem 277:13\u201322","journal-title":"J Biol Chem"},{"key":"132_CR28","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H Dohner","year":"2003","unstructured":"Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al (2003) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910\u20131916","journal-title":"N Engl J Med"},{"key":"132_CR29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V114.22.671.671","volume":"114","author":"JC Strefford","year":"2009","unstructured":"Strefford JC, Parker H, Parker A, Robinson H, Chaplin T, Chen X et al (2009) 13q deletion size predicts disease progression and response to treatment in patients with chronic lymphocytic leukaemia. Blood 114:671","journal-title":"Blood"},{"key":"132_CR30","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood.V106.11.5019.5019","volume":"106","author":"AR Pettitt","year":"2005","unstructured":"Pettitt AR, Emmens CJ, Lin K, Harris RJ (2005) Chronic lymphocytic leukaemia patients with a biallelic deletion of 13q14 have a more favourable profile of prognostic factors compared with cases that have a monoallelic 13q14 deletion. Blood 106:5019","journal-title":"Blood"},{"key":"132_CR31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3324\/haematol.13862","volume":"94","author":"JA Hern\u00e1ndez","year":"2009","unstructured":"Hern\u00e1ndez JA, Rodr\u00edguez AE, Gonz\u00e1lez M et al (2009) A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia. Haematologica 94:364\u2013371","journal-title":"Haematologica"},{"issue":"8","key":"132_CR32","doi-asserted-by":"publisher","first-page":"e44315","DOI":"10.1371\/journal.pone.0044315","volume":"7","author":"MR Ambrosio","year":"2012","unstructured":"Ambrosio MR, Piccaluga PP, Ponzoni M, Rocca BJ, Malagnino V, Onorati M et al (2012) The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin. PLoS One 7(8):e44315. doi: 10.1371\/journal.pone.0044315","journal-title":"PLoS One"},{"issue":"6","key":"132_CR33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.leukres.2013.02.008","volume":"37","author":"E Porpaczy","year":"2013","unstructured":"Porpaczy E, Tauber S, Bilban M et al (2013) Lipoprotein lipase in chronic lymphocytic leukaemia - strong biomarker with lack of functional significance. Leuk Res 37(6):631\u2013636","journal-title":"Leuk Res"},{"issue":"3","key":"132_CR34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.leukres.2009.07.032","volume":"34","author":"M Mansouri","year":"2010","unstructured":"Mansouri M, Sevov M, Fahlgren E, Tobin G, Jondal M, Osorio L, Roos G, Olivecrona G, Rosenquist R (2010) Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity. Leuk Res 34(3):301\u2013306","journal-title":"Leuk Res"},{"key":"132_CR35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.leu.2405058","volume":"22","author":"CP Pallasch","year":"2008","unstructured":"Pallasch CP, Schwamb J, Konigs S, Schulz A, Debey S, Kofler D et al (2008) Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia 22:585\u2013592","journal-title":"Leukemia"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0132-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-016-0132-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0132-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T18:36:45Z","timestamp":1601145405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-016-0132-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1007\/s12253-016-0132-z","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,18]]}}}